384 related articles for article (PubMed ID: 31331325)
21. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
[TBL] [Abstract][Full Text] [Related]
22. Icariside Ⅱ attenuates bleomycin-induced pulmonary fibrosis by modulating macrophage polarization.
Deng L; Ouyang B; Shi H; Yang F; Li S; Xie C; Du W; Hu L; Wei Y; Dong J
J Ethnopharmacol; 2023 Dec; 317():116810. PubMed ID: 37331450
[TBL] [Abstract][Full Text] [Related]
23. Protective effects of microbial biosurfactants produced by Bacillus halotolerans and Candida parapsilosis on bleomycin-induced pulmonary fibrosis in mice: Impact of antioxidant, anti-inflammatory and anti-fibrotic properties via TGF-β1/Smad-3 pathway and miRNA-326.
Mousa AM; Nooman MU; Abbas SS; Gebril SM; Abdelraof M; Al-Kashef AS
Toxicol Appl Pharmacol; 2024 May; 486():116939. PubMed ID: 38643951
[TBL] [Abstract][Full Text] [Related]
24. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.
Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X
Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840
[TBL] [Abstract][Full Text] [Related]
26. Rehmannia Radix Extract Relieves Bleomycin-Induced Pulmonary Fibrosis in Mice via Transforming Growth Factor β1 (TGF-β1).
Hu X; Zhu D
Med Sci Monit; 2020 Dec; 26():e927240. PubMed ID: 33259471
[TBL] [Abstract][Full Text] [Related]
27. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.
Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH
Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406
[TBL] [Abstract][Full Text] [Related]
28. Mutant soluble ectodomain of fibroblast growth factor receptor-2 IIIc attenuates bleomycin-induced pulmonary fibrosis in mice.
Yu ZH; Wang DD; Zhou ZY; He SL; Chen AA; Wang J
Biol Pharm Bull; 2012; 35(5):731-6. PubMed ID: 22687409
[TBL] [Abstract][Full Text] [Related]
29. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
[TBL] [Abstract][Full Text] [Related]
30. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
Kim S; Lim JH; Woo CH
Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
[TBL] [Abstract][Full Text] [Related]
31. Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation.
Wang C; Song X; Li Y; Han F; Gao S; Wang X; Xie S; Lv C
PLoS One; 2013; 8(8):e70725. PubMed ID: 23967091
[TBL] [Abstract][Full Text] [Related]
32. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
[TBL] [Abstract][Full Text] [Related]
33. The matricellular protein CCN1 enhances TGF-β1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury.
Kurundkar AR; Kurundkar D; Rangarajan S; Locy ML; Zhou Y; Liu RM; Zmijewski J; Thannickal VJ
FASEB J; 2016 Jun; 30(6):2135-50. PubMed ID: 26884454
[TBL] [Abstract][Full Text] [Related]
34. Specific Features of Fibrotic Lung Fibroblasts Highly Sensitive to Fibrotic Processes Mediated via TGF-β-ERK5 Interaction.
Kadoya K; Togo S; Tulafu M; Namba Y; Iwai M; Watanabe J; Okabe T; Jin J; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Takeda T; Kondo N; Takahashi K
Cell Physiol Biochem; 2019; 52(4):822-837. PubMed ID: 30946557
[TBL] [Abstract][Full Text] [Related]
35. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
36. Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo.
Wang Y; Li R; Chen L; Tan W; Sun Z; Xia H; Li B; Yu Y; Gong J; Tang M; Ji Y; Yuan S; Shanglong Yao ; Shang Y
Shock; 2015 Nov; 44(5):496-502. PubMed ID: 26196843
[TBL] [Abstract][Full Text] [Related]
37. Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice.
Liu W; Wan J; Han JZ; Li C; Feng DD; Yue SJ; Huang YH; Chen Y; Cheng QM; Li Y; Luo ZQ
Respir Res; 2013 Oct; 14(1):101. PubMed ID: 24098933
[TBL] [Abstract][Full Text] [Related]
38. Antifibrotic effects of cyclosporine A on TGF-β1-treated lung fibroblasts and lungs from bleomycin-treated mice: role of hypoxia-inducible factor-1α.
Yamazaki R; Kasuya Y; Fujita T; Umezawa H; Yanagihara M; Nakamura H; Yoshino I; Tatsumi K; Murayama T
FASEB J; 2017 Aug; 31(8):3359-3371. PubMed ID: 28446589
[TBL] [Abstract][Full Text] [Related]
39. Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin.
Zhou Y; Koli K; Hagood JS; Miao M; Mavalli M; Rifkin DB; Murphy-Ullrich JE
Am J Pathol; 2009 Jan; 174(1):21-33. PubMed ID: 19056849
[TBL] [Abstract][Full Text] [Related]
40. Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway.
Li A; Xiao X; Feng ZL; Chen X; Liu LJ; Lin LG; Lu JJ; Zhang LL
Toxicol Appl Pharmacol; 2020 Jan; 389():114882. PubMed ID: 31953203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
